PharVision Advisers »

Bowhead Specialty Hldgs shares owned by PharVision Advisers

Quarter-by-quarter ownership of Bowhead Specialty Hldgs (BOW) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Bowhead Specialty Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Bowhead Specialty Hldgs held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bowhead Specialty Hldgs by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $608k 23k 27.04

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Bowhead Specialty Hldgs

Gallatin Point Capital
American Family Investments
Victory Capital Management
Vanguard Group
American Century Companies
BlackRock
Polar Capital Holdings
Daniel D. Thurber
Philadelphia Financial Management of San Francisco
Morgan Stanley
Millennium Management
Geode Capital Management
Two Sigma Investments
State Street Corporation
Qube Research & Technologies

View all funds holding Bowhead Specialty Hldgs